JBS Stock Analysis: JBS | NYSE
Packaged Foods | NYSE, USA | Market Cap: 39.172m USD | 12M Return: -1.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 75.5M
EPS Trend: 83.5%
Rev. Trend: 96.5%
Warnings
Tailwinds
No distinct edge detected
Seasonality 1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
JBS N.V. is a global processor of animal proteins, with operations spanning beef, pork, lamb, and poultry, complemented by prepared foods and a diversified portfolio of related businesses such as leather, collagen, hygiene products, metal packaging, and biodiesel. The company sells under numerous consumer-facing brands, including Seara, Pilgrims, Moy Park, Friboi, and Swift. Founded in 1953 and headquartered in Amstelveen, the Netherlands, JBS operates a vertically integrated model that extends from livestock production to branded packaged foods, allowing it to capture value across the protein supply chain. The meat processing industry is generally characterized by stable consumer demand, benefiting from its position in the defensive Consumer Staples sector.
- US beef margins expand as cattle herd shrinks
- Seara branded prepared foods drive higher margin growth
- Pilgrims Pride earnings recover on lower feed costs
| Net Income: 9.55b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -4.53 > 1.0 |
| NWC/Revenue: 6.37% < 20% (prev 8.67%; Δ -2.30% < -1%) |
| CFO/TA 0.07 > 3% & CFO 15.2b > Net Income 9.55b |
| Net Debt (103b) to EBITDA (35.0b): 2.95 < 3 |
| Current Ratio: 1.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.08b) vs 12m ago -51.40% < -2% |
| Gross Margin: 12.32% > 18% (prev 15.03%; Δ -2.72% > 0.5%) |
| Asset Turnover: 202.1% > 50% (prev 184.5%; Δ 17.52% > 0%) |
| Interest Coverage Ratio: 3.09 > 6 (EBIT TTM 22.5b / Interest Expense TTM 7.26b) |
| A: 0.13 (Total Current Assets 90.8b - Total Current Liabilities 60.4b) / Total Assets 233b |
| B: 0.00 (Retained Earnings 1.15b / Total Assets 233b) |
| C: 0.10 (EBIT TTM 22.5b / Avg Total Assets 236b) |
| D: 0.23 (Book Value of Equity 42.4b / Total Liabilities 186b) |
| Altman-Z'' = 1.75 = BBB |
| DSRI: 1.19 (Receivables 25.9b/20.1b, Revenue 477b/442b) |
| GMI: 1.22 (GM 15.03% / 12.32%) |
| AQI: 1.46 (AQ_t 0.35 / AQ_t-1 0.24) |
| SGI: 1.08 (Revenue 477b / 442b) |
| TATA: -0.02 (NI 9.55b - CFO 15.2b) / TA 233b) |
| Beneish M = -2.34 (Cap -4..+1) = BBB |
As of July 13, 2026, the stock is trading at USD 11.91 with a total of 3,826,550 shares traded. Over the past week, the price has changed by -2.85%, over one month by -5.02%, over three months by -27.52% and over the past year by -1.27%.
Current recommended Stop Loss: 11.30 (which is 5.1% or 1.6 ATR below the current price).
JBS has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy JBS.
- StrongBuy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 19.2 | 61% |
P/E Trailing = 7.2622
P/E Forward = 3.8715
P/S = 0.4438
P/B = 4.6862
Revenue TTM = 477b USD
EBIT TTM = 22.5b USD
EBITDA TTM = 35.0b USD
Long Term Debt = 20.5b USD (from longTermDebt, last quarter)
Short Term Debt = 6.21b USD (from shortTermDebt, last quarter)
Debt = 121b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.78b
Net Debt = 103b USD (calculated: Debt 121b - CCE 17.8b)
Enterprise Value = 142b USD (39.2b + Debt 121b - CCE 17.8b)
Interest Coverage Ratio = 3.09 (Ebit TTM 22.5b / Interest Expense TTM 7.26b)
EV/FCF = 62.25x (Enterprise Value 142b / FCF TTM 2.29b)
FCF Yield = 1.61% (FCF TTM 2.29b / Enterprise Value 142b)
FCF Margin = 0.48% (FCF TTM 2.29b / Revenue TTM 477b)
Net Margin = 2.00% (Net Income TTM 9.55b / Revenue TTM 477b)
Gross Margin = 12.32% ((Revenue TTM 477b - Cost of Revenue TTM 418b) / Revenue TTM)
Gross Margin QoQ = 10.42% (prev 12.08%)
Tobins Q-Ratio = 0.61 (Enterprise Value 142b / Total Assets 233b)
Interest Expense / Debt = 6.00% (Interest Expense 7.26b / Debt 121b)
Taxrate = 14.20% (1.73b / 12.2b)
NOPAT = 19.3b (EBIT 22.5b * (1 - 14.20%))
Current Ratio = 1.50 (Total Current Assets 90.8b / Total Current Liabilities 60.4b)
Debt / Equity = 2.85 (Debt 121b / totalStockholderEquity, last quarter 42.4b)
Debt / EBITDA = 2.95 (Net Debt 103b / EBITDA 35.0b)
Debt / FCF = 45.14 (Net Debt 103b / FCF TTM 2.29b)
Total Stockholder Equity = 45.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.04% (Net Income 9.55b / Total Assets 233b)
RoE = 20.90% (Net Income TTM 9.55b / Total Stockholder Equity 45.7b)
RoCE = 33.93% (EBIT 22.5b / Capital Employed (Equity 45.7b + L.T.Debt 20.5b))
RoIC = 11.98% (NOPAT 19.3b / Invested Capital 161b)
WACC = 5.39% (E(39.2b)/V(160b) * Re(6.15%) + D(121b)/V(160b) * Rd(6.00%) * (1-Tc(0.14)))
Discount Rate = 6.15% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -24.34 | Cagr: -25.25%
[DCF] Terminal Value 73.10% ; FCFF base≈6.66b ; Y1≈5.84b ; Y5≈4.72b
[DCF] Fair Price = N/A (negative equity: EV 75.7b - Net Debt 103b = -27.6b; debt exceeds intrinsic value)
EPS Correlation: 83.48 | EPS CAGR: 278.1% | SUE: N/A | # QB: 0
Revenue Correlation: 96.48 | Revenue CAGR: 13.27% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.63 | Chg30d=-5.44% | Revisions=-40% | Analysts=4
EPS next Quarter (2026-09-30): EPS=2.18 | Chg30d=-2.49% | Revisions=-40% | Analysts=4
EPS current Year (2026-12-31): EPS=7.03 | Chg30d=-2.82% | Revisions=-40% | GrowthEPS=-38.2% | GrowthRev=+3.8%
EPS next Year (2027-12-31): EPS=9.02 | Chg30d=+6.84% | Revisions=+0% | GrowthEPS=+28.2% | GrowthRev=+2.2%
[Analyst] Revisions Ratio: -55% (up=1, down=7)